Mosaic Stock Rises As Analysts Boost Targets And Debt Falls

Mosaic Company (The) stocks have been trading up by 4.54 percent following upbeat fertilizer demand and pricing news.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading MOS

JOIN 50,000+ ACTIVE TRADERS

What Traders Need To Know

RBC kept an Outperform on Mosaic Company (The) with a $27 target, leaning on a recovery in phosphate margins and better free cash flow from lower capex and a large H2 working-capital reversal.
BNP Paribas lifted its MOS target to $32 and stayed Outperform, while the wider analyst view is overweight with average targets near $27.
Mizuho nudged its MOS price target from $24 to $25 but stuck with a Neutral call, pointing to only modest near-term upside.
Q2 2026 adjusted EPS landed at $0.13 versus $0.12 expected, a small beat that supports the improving tone without signaling a full turnaround.
Management launched and then completed up to $1.4B in note tenders due 2027–2029, trimming and refinancing debt while also rolling out Renuvis Enzara through Mosaic Biosciences.

Weekly Update Aug 17 – Aug 21, 2026: On Friday, August 21, 2026 Mosaic Company (The) stock [NYSE: MOS] is trending up by 4.54%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Materials industry expert:

Analyst sentiment – positive

Mosaic currently operates from a position of cyclical weakness but structural relevance in global fertilizers. Revenues of ~$12.1B are down 10% over three years, with gross margin at 11% and EBIT margin deeply pressured, reflected in negative LTM ROE and net loss in Q2. Leverage is manageable (D/E ~0.54, interest coverage 6.3x), but liquidity is tight with a 0.1 quick ratio and only ~$294M cash. The stock trades at just ~0.6x book and ~0.6x sales, embedding distressed-cycle expectations despite substantial, long-lived potash and phosphate assets.

Technically, MOS has flipped into a short-term upside acceleration: the weekly strip from 21.2 to 24.6 shows a near-16% move in four sessions with successively higher highs and higher lows, confirming a new uptrend. Intraday 5‑minute tape (not shown here) supports this with persistent buying near the close and rising volume into strength. First actionable level is $23.30–23.50 as near-term support; a pullback and hold there is a low-risk entry, with stops just below $22.80 to manage downside.

More Breaking News

Near term, the stock is catalyzed by gradually improving sentiment: Mizuho’s $25, RBC’s $27, and BNP Paribas’ $32 targets all point above spot, supported by expectations for phosphate margin normalization into 2027 and improving free cash flow via lower capex and working-capital release. Debt-tender activity de-risks the maturity stack versus Materials and Ag peers. I see a 6–12 month fair value range of $26–28, with support at $22.50 and resistance at $27.50–28.

Quick Financial Overview

Mosaic Company (The) is trading in the mid-$20s, with the weekly chart showing a steady climb from roughly $21 early in the period to a $24.60 close. That is a clean, stair-step advance across several sessions, suggesting dip buyers are active and shorts are backing off. On the intraday tape, MOS held a tight intraday range around $24.40–$24.70 for most of the afternoon before closing strong at the highs, which often signals accumulation rather than distribution.

Fundamentally, MOS is a low-multiple, asset-heavy cyclical name. Revenue runs around $12.05B, with a price-to-sales ratio near 0.58 and price-to-book roughly 0.62, which tells you the stock is trading below stated equity value. Margins are currently thin, with EBIT margin only about 0.4% and gross margin near 11%, while trailing profit margins and some return metrics are negative. That lines up with the narrative of depressed fertilizer pricing and under-earning assets.

On the balance sheet, leverage is moderate with total debt-to-equity at 0.54 and interest coverage around 6.3 times, which is manageable for a commodity producer. The current ratio near 1.3 shows MOS can cover near-term obligations, though a quick ratio of 0.1 reflects heavy inventory and working-capital intensity. The tender offers to repurchase and refinance up to $1.4B of notes due 2027–2029, followed by completion of a substantial portion, reduce near- to medium-term maturities and slightly de-risk the structure. Q2 2026 free cash flow was negative at about -$152.9M, but analysts at RBC and BNP Paribas are focused on improved free cash flow ahead as capex comes down and working capital reverses.

Conclusion

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!